Eric Hwang

Eric Hwang is a well-regarded corporate lawyer with extensive experience representing technology and life sciences clients on a wide range of transactions, including complex, cross-border mergers and acquisitions; strategic joint ventures; venture capital, private equity and corporate investments; and corporate governance matters.

Drawing from his diverse background, which includes both in-house and business-side leadership roles, Mr. Hwang has a strong understanding of the type and scope of services that clients are seeking from their outside advisors. Mr. Hwang's insight into strategic matters, financial analysis and business operations allows him to quickly calibrate and provide practical, contextualized advice and business-minded solutions to complex, multi-threaded issues.

Mr. Hwang joined WilmerHale in 2016 after spending several years at another global law firm, where he focused on representing technology, pharmaceutical, and healthcare clients in mergers and acquisitions and other strategic transactions.

Prior to rejoining private practice in 2012, Mr. Hwang was senior counsel and later director of corporate development at Oracle Corporation, where he managed all aspects of Oracle's acquisitions—including nearly half of its announced acquisitions over a three-and-a-half year time period—and played a key role in the acquisitions of BEA Systems and Sun Microsystems. He was also a key contributor to Oracle's M&A program, establishing precedent and repeatable practices that have since been used in more than 75 acquisitions. As both a business and legal leader during Oracle's acquisition spree, Mr. Hwang played an important role in helping M&A become one of Oracle's key drivers of growth, with annual revenue growing from $18 billion in 2007 to more than $37 billion in 2012.

Speaking Engagements

  • "Planning for Exit—Why It's Never Too Early," December 2017: QuickLaunch University Webinar, Speaker
  • "Tales From the Buy-Side: Things That Buyers Care About When Negotiating an Acquisition,"August 2017: ACC-SFBA August CLE Program, Palo Alto and San Francisco, Speaker
  • "Venture Capital Term Sheets: What to Know," May 2017: tempCFO, Inc., Webinar, Speaker
  • "Getting M&A Done in a Digital World – Navigating Cybersecurity and Other Regulatory Pitfalls," March 2017: ACC-SFBA March Madness 2017, Santa Clara, Speaker
  • "Exits for Startups," October 2016: Cardinal Pitch Club Startup 101, Palo Alto, Speaker
  • "Successfully partnering with outside counsel on M&A transactions: Models of collaboration – outsourcing and insourcing M&A Legal functions," December 2015: Association for Corporate Counsel – Bay Area Chapter, San Francisco and Palo Alto, Speaker
  • "Trends in Tech Deals," November 2015: Dagens Industri Annual Conference, Stockholm, Speaker
  • "Legal Issues That May Surprise US Acquirers in Western European M&A," August 2014: Palo Alto, Panelist
  • "A View from Silicon Valley: A Review of Trends in Technology M&A and Venture Transactions," April 2014: Tokyo and Palo Alto, Speaker
  • "Kicking the Tires: Anticorruption Due Diligence in M&A and Investment Transactions," April 2014: Palo Alto, Speaker
  • "Corporate Development and the In-House Counsel – understanding your counterpart and the art of wearing two hats," December 2013: Association for Corporate Counsel – Bay Area Chapter, San Francisco and Palo Alto, Speaker


  • Over the course of his career, Mr. Hwang has completed more than 60 transactions, representing an aggregate value of more than $30 billion. Some of his representations include:

    • advising Gilead Sciences, Inc. (NASDAQ: GILD), a research-based biopharmaceutical company, in its sale of GS-6637 and related assets to Amygdala Neurosciences, Inc., a biopharmaceutical company focused on addiction disorders;
    • advising CapitalG, Alphabet Inc.'s investment fund, in its acquisition of a minority stake in private equity firm TPG's acquisitions of RCN Telecom Services LLC and Grande Communications Networks LLC, two cable providers;
    • advising a global Fortune 500 technology company in multiple acquisitions, including its acquisition of substantially all of the assets related to the mobile phone chipset business of a US-based telecommunications company and its acquisition of a provider of over-the-air software update technology;
    • advising Pivotal Software, Inc., a data and analytics software and services provider, in multiple transactions, including its UK-based acquisitions of Cloud Credo Ltd., a Cloud Foundry development and services provider, and StayUp.IO, a provider of software tools in the Cloud Foundry log analysis space, and its joint venture with Telstra Corporation Limited (ASX: TLS), one of Australia's largest telecommunications and media companies;
    • advising Khazanah Nasional Berhad, the sovereign wealth fund of Malaysia, in numerous investments, including its investment in Palantir;
    • advising an SEO and content marketing company in its M&A and strategic transactions;
    • advising a leading listed technology company in its investment in a machine learning company;
    • advising Voltage Security, Inc., a provider of data-centric encryption and tokenization technology, in its sale to Hewlett-Packard Company, an American multinational information technology company;
    • advising Merck KGaA (XETRA: MRK), a German chemical and pharmaceutical company and a life sciences business, and Merck Millipore, its life sciences business, in its acquisition of worldwide rights to a molecule counting technology from Singulex Inc.;
    • advising AIXTRON SE (NASDAQ: AIXG), a leading manufacturer of deposition systems for the semiconductor industry, in its acquisition of PlasmaSi, Inc., a provider of OLED encapsulation technology;
    • advising NTT Communications, the ICT solutions and international communications business within the Nippon Telegraph & Telephone Corporation (NYSE: NTT), in its acquisition of RagingWire Data Centers, a provider of data center colocation services;
    • advising Armorize Technologies, Inc., a provider of cloud-based threat and malware detection technology, in its sale to Proofpoint (NASDAQ: PFPT), a provider of security-as-a-service software;
    • advising a global provider of software and custom development services on several complex, multijurisdictional strategic transactions; 
    • advising Synder Filtration, a US membrane technology company, in its establishment of a joint venture to develop certain membrane technologies with a multinational chemical company; and
    • advising Oracle Corporation, a global enterprise technology company, in more than two dozen acquisitions involving a wide range of technology products and deployments, including database, middleware, applications, hardware and on-premise and SaaS.


  • Recommended in the 2017 edition of The Legal 500 United States for M&A/Corporate and Commercial: M&A: Middle-Market ($500m-999m) and M&A/Corporate and Commercial: Venture Capital and Emerging Companies

Insights & News